Yanagihara K, Kadoto J, Kohno S (2001). "Diffuse panbronchiolitis--pathophysiology and treatment mechanisms". International Journal of Antimicrobial Agents. 18 (Suppl 1): S83-7. doi:10.1016/s0924-8579(01)00403-4. PMID11574201.
Homma H, Yamanaka A, Tanimoto S, Tamura M, Chijimatsu Y, Kira S, Izumi T (January 1983). "Diffuse panbronchiolitis. A disease of the transitional zone of the lung". Chest. 83 (1): 63–9. doi:10.1378/chest.83.1.63. PMID6848335.
López-Boado YS, Rubin BK (June 2008). "Macrolides as immunomodulatory medications for the therapy of chronic lung diseases". Current Opinion in Pharmacology. 8 (3): 286–91. doi:10.1016/j.coph.2008.01.010. PMID18339582.
Keicho N, Kudoh S (2002). "Diffuse panbronchiolitis: role of macrolides in therapy". American Journal of Respiratory Medicine. 1 (2): 119–31. doi:10.1007/BF03256601. PMID14720066. S2CID39880028.
Tamaoki J, Kadota J, Takizawa H (November 2004). "Clinical implications of the immunomodulatory effects of macrolides". The American Journal of Medicine. 117 Suppl 9A (9): 5S –11S. doi:10.1016/j.amjmed.2004.07.023. PMID15586558.
Fitzgerald JE, King TE, Lynch DA, Tuder RM, Schwarz MI (August 1996). "Diffuse panbronchiolitis in the United States". American Journal of Respiratory and Critical Care Medicine. 154 (2 Pt 1): 497–503. doi:10.1164/ajrccm.154.2.8756828. PMID8756828.
Martinez JA, Guimarães SM, Ferreira RG, Pereira CA (March 2000). "Diffuse panbronchiolitis in Latin America". The American Journal of the Medical Sciences. 319 (3): 183–5. doi:10.1097/00000441-200003000-00008. PMID10746829.
Yanagihara K, Kadoto J, Kohno S (2001). "Diffuse panbronchiolitis--pathophysiology and treatment mechanisms". International Journal of Antimicrobial Agents. 18 (Suppl 1): S83-7. doi:10.1016/s0924-8579(01)00403-4. PMID11574201.
Homma H, Yamanaka A, Tanimoto S, Tamura M, Chijimatsu Y, Kira S, Izumi T (January 1983). "Diffuse panbronchiolitis. A disease of the transitional zone of the lung". Chest. 83 (1): 63–9. doi:10.1378/chest.83.1.63. PMID6848335.
López-Boado YS, Rubin BK (June 2008). "Macrolides as immunomodulatory medications for the therapy of chronic lung diseases". Current Opinion in Pharmacology. 8 (3): 286–91. doi:10.1016/j.coph.2008.01.010. PMID18339582.
Keicho N, Kudoh S (2002). "Diffuse panbronchiolitis: role of macrolides in therapy". American Journal of Respiratory Medicine. 1 (2): 119–31. doi:10.1007/BF03256601. PMID14720066. S2CID39880028.
Tamaoki J, Kadota J, Takizawa H (November 2004). "Clinical implications of the immunomodulatory effects of macrolides". The American Journal of Medicine. 117 Suppl 9A (9): 5S –11S. doi:10.1016/j.amjmed.2004.07.023. PMID15586558.
Chantarotorn S, Palwatwichai A, Vattanathum A, Tantamacharik D (August 1999). "Diffuse panbronchiolitis, the first case reports in Thailand". Journal of the Medical Association of Thailand = Chotmaihet Thangphaet. 82 (8): 833–8. PMID10511794.
Fitzgerald JE, King TE, Lynch DA, Tuder RM, Schwarz MI (August 1996). "Diffuse panbronchiolitis in the United States". American Journal of Respiratory and Critical Care Medicine. 154 (2 Pt 1): 497–503. doi:10.1164/ajrccm.154.2.8756828. PMID8756828.
Martinez JA, Guimarães SM, Ferreira RG, Pereira CA (March 2000). "Diffuse panbronchiolitis in Latin America". The American Journal of the Medical Sciences. 319 (3): 183–5. doi:10.1097/00000441-200003000-00008. PMID10746829.
Yamanaka A, Saiki S, Tamura S, Saito K (March 1969). "[Problems in chronic obstructive bronchial diseases, with special reference to diffuse panbronchiolitis]". Naika. Internal Medicine (in Japanese). 23 (3): 442–51. PMID5783341.
Keicho N, Kudoh S (2002). "Diffuse panbronchiolitis: role of macrolides in therapy". American Journal of Respiratory Medicine. 1 (2): 119–31. doi:10.1007/BF03256601. PMID14720066. S2CID39880028.